European Pharmaceutical Review

JUNE 29, 2022

As the healthcare sector grows, there is a clear trend towards the expansion of biologic therapeutic drugs and vaccines like the one developed by Novavax. To summarise, bioproduction hurdles include the necessity to be fast, agile and, not to be understated, able to deliver safe and effective vaccines worldwide.

Vaccines 98

Vaccines Documentation 98

European Pharmaceutical Review

DECEMBER 19, 2023

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

Vaccines 111

Vaccines Communication Immunity Immunization 111

Putting Patients First Blog

APRIL 30, 2024

Key Points of Support Conciseness and Focus of Key Information The NHC supports the FDA’s emphasis on beginning the informed consent document with concise, focused presentations of key information. The importance of using plain language in health communications is well-documented in literature.

Documentation 52

Documentation Communication Mayo Clinic Drug Development 52

Putting Patients First Blog

JULY 22, 2024

This includes wholesalers, payers, and other entities involved in pricing and distribution, all of which significantly influence the availability and cost of medical products, including drugs, biologics, vaccines, and devices. Although these considerations extend beyond the current RFI, the NHC believes they warrant attention. Pistollato, M.,

Documentation 52

Documentation Vaccines 52

pharmaphorum

JANUARY 9, 2023

1 Kenya, for example, entered the pandemic with no human vaccines manufacturing facility and established the BioVax institute for local vaccine manufacture with a major plant investment starting in 2023. For pharma, the impact in critical areas such as the performance of newly marketed innovation has already been documented.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 98

The Digital Apothecary

APRIL 26, 2019

The authors went back and analyzed much of the past data using previous methods to estimate costs in dollars and reflect inflation for 2016 prices. billion in 2016 US dollars" with a low end of $495.3 Pharmacists by and large are still on the bench (though now vaccinating as well) and pushing their drug filling process to meet metrics.

Medication Therapy Management (MTM) 130

Medication Therapy Management (MTM) Communication Packaging Hospitals 130

PharmaShots

JUNE 1, 2023

PDC*line is much more potent than conventional dendritic cell-based vaccines in priming and boosting antitumor antigen-specific cytotoxic T-cells, including the T-cells specific for neoantigens, and is synergistic with checkpoint inhibitors. The technology can potentially be applied to any type of cancer. 2015; Zhu et al.,

Immunity 40

Immunity Immunization Vaccines Health and Personal Care Stores 40